Search

Jeff Tyner group

Jeff Tyner group

September 14, 2023

(left to right): Nicola Long, Jeffrey Tyner, Ph.D., Kara Johnson, and Cristina Tognon, Ph.D. co-authored new research published in Cancer Cell. Their findings are the latest from the OHSU Knight Cancer Institutes Beat AML platform for analyzing the cancer cell gene expression, drug sensitivities, and medical outcomes of more than 800 people with acute myeloid leukemia. (OHSU/Christine Torres Hicks)

Jeff Tyner, Ph.D.

Jeff Tyner, Ph.D.

September 14, 2023

Jeffrey Tyner, Ph.D., co-led new research that zeros in on a potential drug target to stop acute myeloid leukemia. (OHSU/Christine Torres Hicks)

Shannon McWeeney, Ph.D.

Shannon McWeeney, Ph.D.

September 14, 2023

Shannon McWeeney, Ph.D., professor and head of the Division of Bioinformatics and Computational Biology and an OHU Knight Cancer Institute researcher, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeff Tyner, Ph.D.

Jeff Tyner, Ph.D.

September 14, 2023

Jeffrey Tyner, Ph.D., professor of cell, developmental and cancer biology in the OHSU School of Medicine. (OHSU/Christine Torres Hicks)

OHSU experts tapped for national Artificial Intelligence initiative

OHSU experts tapped for national Artificial Intelligence initiative

September 14, 2023

David Dorr, M.D., M.S., left, chief research information officer and professor of medical informatics and clinical epidemiology in the OHSU School of Medicine, Kyle Ellrott, Ph.D., center, assistant professor of biomedical engineering in the OHSU School of Medicine, is part of the Bridge Center, and Shannon McWeeney, Ph.D., right, chief data officer for the OHSU Knight Cancer Institute. (OHSU)

See More Stories